Charles Albright, Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 10,000 shares at $35.00 ($350K) on 2018-05-23, disclosed to the SEC on 2018-05-25.
Open-market sale of $350k EDIT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EDIT | SELL | 2020-12-08 | $1.6M | — | Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |